Advertisement

Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial

  • Alexandra Philipsen
  • Erika Graf
  • Ludger Tebartz van Elst
  • Thomas Jans
  • Andreas Warnke
  • Bernd Hesslinger
  • Dieter Ebert
  • Manfred Gerlach
  • Swantje Matthies
  • Michael Colla
  • Christian Jacob
  • Esther Sobanski
  • Barbara Alm
  • Michael Rösler
  • Gabriele Ihorst
  • Silke Gross-Lesch
  • Laura Gentschow
  • Bernhard Kis
  • Michael Huss
  • Klaus Lieb
  • Michael Schlander
  • Mathias Berger
Original Article

Abstract

ADHD is a serious risk factor for co-occurring psychiatric disorders and negative psychosocial consequences in adulthood. Previous trials on psychotherapeutic concepts for adult ADHD are based on behavioural (cognitive behavioural and dialectical behavioural) psychotherapeutic approaches and showed significant effects. The aim of our study group (COMPAS) is to carry out a first randomized and controlled multicentre study to evaluate the effects of a disorder tailored psychotherapy in adult ADHD compared to clinical management in combination with psychopharmacological treatment or placebo. A total of 448 adults with ADHD according to DSM-IV will be treated at seven university sites in Germany. In a four-arm design, patients are randomized to a manualized dialectical behavioural therapy (DBT) based group programme plus methylphenidate or placebo or clinical management plus methylphenidate or placebo with weekly sessions in the first 12 weeks and monthly sessions thereafter. Therapists are graduated psychologists or physicians. Treatment integrity is established by independent supervision. Primary endpoint (ADHD symptoms measured by the Conners Adult Rating Scale) is rated by interviewers blind to the treatment allocation. Intention-to-treat analysis will be performed within a linear regression model (Current Controlled Trials ISRCTN54096201). The trial is funded by the German Federal Ministry of Research and Education (01GV0606) and is part of the German network for the treatment of ADHD in children and adults (ADHD-NET).

Keywords

ADHD Adult Treatment Psychotherapy Methylphenidate RCT 

Notes

Acknowledgments

Our network on psychotherapy of ADHD is supported by the German Federal Ministry of Education and Research (BMBF; 01GV0605, 01GV0606). Members of the COMPAS group (Comparison of methylphenidate and psychotherapy in adult ADHD study, coordinating investigator: PD Dr. A. Philipsen, Freiburg) are our colleagues at the study sites at Wuerzburg (Department of Child and Adolescent Psychiatry and Psychotherapy, Director: Prof. Dr. A. Warnke, coordinator of the ADHD-NET), Freiburg (Department of Psychiatry and Psychotherapy, Director: Prof. Dr. M. Berger), Homburg (Saarland University Hospital and Saarland University Faculty of Medicine: Institute for Forensic Psychology and Psychiatry, Director: Prof. Dr. M. Roesler), Mannheim (Central Institute for Mental Health: Clinic for Psychiatry and Psychotherapy, Director: Prof. Dr. A. Meyer-Lindenberg), Wuerzburg (Department of Psychiatry, Psychosomatics and Psychotherapy, Director: Prof. Dr. J. Deckert; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Director: Prof. Dr. A. Warnke), Mainz (Department of Psychiatry and Psychotherapy, Director: Prof. K. Lieb; Department of Child and Adolescent Psychiatry and Psychotherapy, Director: Prof. M. Huss), Essen (Department of Psychiatry and Psychotherapy, Director: Prof. J. Wiltfang), members of the Clinical Trials Center at Freiburg (Director: Prof. Dr. H. Maier-Lenz) as well as members of the Data Monitoring and Safety Committee (Prof. Dr. Dr. H. Remschmidt, Prof. Dr. G. Wassmer, PD Dr. N. Wodarz). Independent supervision is carried out by staff members of the Institute for Psychology of Freiburg University in cooperation with colleagues in private practice. The three other projects of our network on psychotherapy of ADHD (coordinator: Prof. Dr. A. Warnke, Wuerzburg) are coordinated by Prof. A. Warnke and Dr. T. Jans (Wuerzburg, ADHD in Mothers and Children (AIMAC) Study), Prof. Dr. L. Tebartz van Elst (Freiburg, functional and morphometric brain mapping) and Prof. Dr. K.-P. Lesch (Wuerzburg, molecular genetics). We gratefully thank all participating patients and all our Partners for their cooperation. We feel obliged to Dr. Fischer (MEDICE Arzneimittel Puetter GmbH & Co. KG) for his support in providing the trial medication and in preparing the study protocol and case report forms as well as his assistance in SAE management. German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung, BMBF, ref: 01GV0606). MEDICE Arzneimittel Pütter GmbH & Co. KG (trial medication).

References

  1. Beck AT, Ward CH, Mendelson M, Mock H, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  2. Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65 (Suppl 3): 3–7 (review)Google Scholar
  3. Birnbaum HG, Kessler RC, Lowe SW et al (2005) Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21(2):195–206CrossRefPubMedGoogle Scholar
  4. Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K (2009) Evaluation of Group Cognitive Behavioral Therapy for Adults With ADHD. J Atten Disord 12(5):434–441CrossRefPubMedGoogle Scholar
  5. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMedGoogle Scholar
  6. Christiansen H, Kis B, Hirsch O, Philipsen A, Henneck M, Panczuk A, Pietrowsky R, Hebebrand J, Schimmelmann BG (2010) German validation of the Conners Adult ADHD Rating Scales-self-report (CAARS-S) I: Factor structure and normative data. Eur PsychiatryGoogle Scholar
  7. Conners CK, Ehrhard D, Sparrow D (1999) CAARS adult ADHD rating scales. MHS, New YorkGoogle Scholar
  8. Derogatis LR (1977) SCL-90-R: administration, scoring and procedures manual II. Clinical Psychometric Research, Towson, MDGoogle Scholar
  9. Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im erwachsenenalter–leitlinien auf der basis eines expertkonsensus mit unterstutzung der DGPPN. Nervenarzt 74:939–946PubMedGoogle Scholar
  10. Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29(2):321–326PubMedGoogle Scholar
  11. Faraone SV, Spencer T, Aleardi M et al (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharm 24:24–29CrossRefGoogle Scholar
  12. Franke GH (2002) SCL-90-R. Die symptom-checkliste von derogatis–deutsche version. Beltz, WeinheimGoogle Scholar
  13. Guy W (1976). ECDEU Assessment manual for psychopharmacologyGoogle Scholar
  14. Hesslinger B, Tebartz van Elst L, Nyberg E et al (2002) Psychotherapy of attention deficit hyperactivity disorder in adults - A pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252:177–184PubMedGoogle Scholar
  15. Hesslinger B, Philipsen A, Richter H (2003) Psychotherapy in adult ADHD. Verhaltenstherapie 13:276–282CrossRefGoogle Scholar
  16. Hesslinger B, Philipsen A, Richter H et al (2004) Psychotherapie der ADHS im Erwachsenenalter–ein Arbeitsbuch. Hogrefe, GoettigenGoogle Scholar
  17. Jacob CP, Philipsen A, Ebert D et al (2008) Multimodale therapie der aufmerksamkeitsdefizit-/hyperaktivitaetsstoerung im erwachsenenalter. Nervenarzt 79:801–808CrossRefPubMedGoogle Scholar
  18. Knapp M, Mangalore R (2007) The trouble with QALYs. Epidemiol Psychiatr Soc 26:289–293Google Scholar
  19. Lehrl S (1977) Mehrfachwahl-Wortschatz-Intelligenztest Form B. Straube, ErlangenGoogle Scholar
  20. Linehan MM (1993) Cognitive-behavioral treatment of borderline personality disorder. Guildford Press, New YorkGoogle Scholar
  21. Mannuzza S, Klein G, Bessler A et al (1998) Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493–498PubMedGoogle Scholar
  22. Matza LS (2007) Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res 16:1511–1520CrossRefPubMedGoogle Scholar
  23. Medori R, Ramos-Quiroga JA, Casas M et al (2008) A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 63(10):981–989CrossRefPubMedGoogle Scholar
  24. Mick E, Faraone SV, Spencer T, Zhang HF, Biederman J (2008) Assessing the validity of the quality of life enjoyment and satisfaction questionnaire short form in adults with ADHD. J Atten Disord 11(4):504–509CrossRefPubMedGoogle Scholar
  25. Philipsen A (2006) Differential diagnosis and comorbidity of attentiondeficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults. Eur Arch Psychiatr Clin Neurosci 256(Suppl 1):i42–i46CrossRefGoogle Scholar
  26. Philipsen A, Richter H, Peters J et al (2007) Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicenter study. J Nerv Ment Dis 195:1013–1019CrossRefPubMedGoogle Scholar
  27. Philipsen A, Limberger MF, Lieb K et al (2008) Attention deficit/hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 192:118–123CrossRefPubMedGoogle Scholar
  28. Philipsen A, Feige B, Hesslinger B et al (2009) Borderline typical symptoms in adult patients with attention deficit/hyperactivity disorder. ADHD Atten Defic Hyperact Disord 1:11–18CrossRefGoogle Scholar
  29. Retz-Junginger P, Retz W, Blocher D et al (2002) Wender utah rating scale (WURS-k). Nervenarzt 73:830–838CrossRefPubMedGoogle Scholar
  30. Retz-Junginger P, Retz W, Blocher D et al (2003) Reliabilitaet und Validitaet der Wender-Utah-Rating-Scale Kurzform. Retrospektive Erfassung von Symptomen aus dem Spektrum der Aufmerksamkeitsdefizit/Hyperaktivitaetsstoerung. Nervenarzt 74:987–993CrossRefPubMedGoogle Scholar
  31. Roesler M, Retz W, Retz-Junginger P et al (2004) Instrumente zur diagnostik der aufmerksamkeitsdefizit-/hyperaktivitaetsstoerung (ADHS) im Erwachsenenalter. Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DC). Nervenarzt 75:888–895Google Scholar
  32. Rösler M, Retz W, Stieglitz RD (2010) Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations–benchmarking instruments for international multicentre trials. Pharmacopsychiatry 43(3):92–98CrossRefPubMedGoogle Scholar
  33. Safren SA, Otto MW, Sprich STE et al (2005) Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43:831–842CrossRefPubMedGoogle Scholar
  34. Salakari A, Virta M, Grönroos N et al (2010) Cognitive-behaviorally-oriented group rehabilitation of adults with ADHD: results of a 6-month follow-up. J Atten Disord 13(5):516–523CrossRefPubMedGoogle Scholar
  35. Schlander M (2007) Health technology assessments by the national institute for health and clinical excellence. A qualitative study. Springer, New YorkGoogle Scholar
  36. Schlander M, Trott GE, Schwarz O (2010). The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness. Nervenarzt 81(3): 289–300 (review German)Google Scholar
  37. Schmitz N, Hartkamp N, Kiuse J et al (2000) The symptom check-list-90-R (SCL-90-R): a German validation study. Qual Life Res 9(2):185–193CrossRefPubMedGoogle Scholar
  38. Secnik K, Swensen A, Lage MJ (2005) Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 23(1):93–102CrossRefPubMedGoogle Scholar
  39. Solanto MV, Marks DJ, Wasserstein J et al (2010) Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 167(8):958–968CrossRefPubMedGoogle Scholar
  40. Stevenson CS, Whitmont S, Bornholt L et al (2002) A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Austr New Z J Psychiatr 36:610–616CrossRefGoogle Scholar
  41. Virta M, Vedenpää A, Grönroos N et al (2008) Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord 12(3):218–226CrossRefPubMedGoogle Scholar
  42. Wender PH, Wolf LE, Wasserstein J (2001) Adults with ADHD: an overview. Ann NY Acad Sci 931:1–16CrossRefPubMedGoogle Scholar
  43. Wilens TE, Faraone SV, Biederman J (2004) Attention deficit/hyperactivity disorder in adults. JAMA 292(5):619–623CrossRefPubMedGoogle Scholar
  44. Wittchen HU, Zaudig M, Fydrich T (1997) SKID–strukturiertes klinisches interview fuer DSM IV. Achse I und II. Hogrefe, GoettingenGoogle Scholar
  45. Zylowska L, Ackerman DL, Yang MH et al (2008) Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord 11(6):737–746CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Alexandra Philipsen
    • 1
  • Erika Graf
    • 2
  • Ludger Tebartz van Elst
    • 1
  • Thomas Jans
    • 3
  • Andreas Warnke
    • 3
  • Bernd Hesslinger
    • 1
  • Dieter Ebert
    • 1
  • Manfred Gerlach
    • 3
  • Swantje Matthies
    • 1
  • Michael Colla
    • 5
  • Christian Jacob
    • 4
  • Esther Sobanski
    • 6
  • Barbara Alm
    • 6
  • Michael Rösler
    • 7
  • Gabriele Ihorst
    • 2
  • Silke Gross-Lesch
    • 4
  • Laura Gentschow
    • 5
  • Bernhard Kis
    • 8
  • Michael Huss
    • 9
  • Klaus Lieb
    • 10
  • Michael Schlander
    • 11
    • 12
  • Mathias Berger
    • 1
  1. 1.Department of Psychiatry and PsychotherapyUniversity Medical Center FreiburgFreiburgGermany
  2. 2.Clinical Trials CenterUniversity Medical Center FreiburgFreiburgGermany
  3. 3.Department of Child and Adolescent Psychiatry, Psychosomatics and PsychotherapyUniversity of WuerzburgWuerzburgGermany
  4. 4.Department of Psychiatry and PsychotherapyUniversity of WuerzburgWuerzburgGermany
  5. 5.Department of PsychiatryCharite–University Medicine BerlinBerlinGermany
  6. 6.Central Institute of Mental Health J5MannheimGermany
  7. 7.Faculty of Medicine, Institute for Forensic Psychology and PsychiatrySaarland UniversityHomburgGermany
  8. 8.Department of Psychiatry and PsychotherapyUniversity of Duisburg-EssenDuisburgGermany
  9. 9.Department of Child and Adolescent Psychiatry and PsychotherapyUniversity Medical CenterMainzGermany
  10. 10.Department of Psychiatry and PsychotherapyUniversity Medical CenterMainzGermany
  11. 11.Institute for Innovation and Valuation in Health Care, INNOVAL HCWiesbadenGermany
  12. 12.Mannheim Medical FacultyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations